Profile for Eyenovia Inc. (EYEN)

$ 2.85   0.04 (+1.42%) Volume: 82.66k 3:59 PM EDT 2-Jul-2020
Business Description:
Eyenovia Inc is a clinical stage biopharmaceutical company. It is engaged in developing a pipeline of ophthalmology products utilizing patented piezo-print technology to deliver micro-therapeutics topically to the eye.
Address: 295 Madison Avenue, Suite 2400, New York, NY, USA, 10017
Telephone: +1 917 289-1117 Website:
Facsimile: N/A Email: [email protected]
CEO: Tsontcho Ianchulev
Employees: 29 Market Cap: 56.36m
Issue Type: CS
Auditor: Marcum LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1682639
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)